Prothena Corp. Plc (PRTA)
8.40
-0.09
(-1.06%)
USD |
NASDAQ |
Aug 06, 11:49
Prothena Total Return Level : 8.49 for Aug. 5, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 05, 2026 | 8.49 |
| August 04, 2026 | 8.49 |
| August 03, 2026 | 8.33 |
| July 31, 2026 | 8.12 |
| July 30, 2026 | 8.41 |
| July 29, 2026 | 8.56 |
| July 28, 2026 | 8.56 |
| July 27, 2026 | 8.70 |
| July 24, 2026 | 8.75 |
| July 23, 2026 | 8.53 |
| July 22, 2026 | 8.44 |
| July 21, 2026 | 8.75 |
| July 20, 2026 | 8.67 |
| July 17, 2026 | 8.66 |
| July 16, 2026 | 8.47 |
| July 15, 2026 | 8.43 |
| July 14, 2026 | 8.64 |
| July 13, 2026 | 8.83 |
| July 10, 2026 | 9.24 |
| July 09, 2026 | 9.64 |
| July 08, 2026 | 9.85 |
| July 07, 2026 | 9.68 |
| July 06, 2026 | 9.50 |
| July 02, 2026 | 9.69 |
| July 01, 2026 | 9.58 |
| Date | Value |
|---|---|
| June 30, 2026 | 9.79 |
| June 29, 2026 | 9.97 |
| June 26, 2026 | 10.02 |
| June 25, 2026 | 9.27 |
| June 24, 2026 | 9.40 |
| June 23, 2026 | 9.55 |
| June 22, 2026 | 9.15 |
| June 18, 2026 | 8.93 |
| June 17, 2026 | 8.49 |
| June 16, 2026 | 8.29 |
| June 15, 2026 | 8.15 |
| June 12, 2026 | 8.25 |
| June 11, 2026 | 8.26 |
| June 10, 2026 | 7.91 |
| June 09, 2026 | 8.47 |
| June 08, 2026 | 8.56 |
| June 05, 2026 | 8.79 |
| June 04, 2026 | 9.25 |
| June 03, 2026 | 8.92 |
| June 02, 2026 | 9.19 |
| June 01, 2026 | 9.59 |
| May 29, 2026 | 10.18 |
| May 28, 2026 | 9.98 |
| May 27, 2026 | 10.03 |
| May 26, 2026 | 10.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alkermes Plc | 49.61 |
| Amarin Corp. Plc | 14.41 |
| Agenus, Inc. | 7.78 |
| Amgen, Inc. | 607.21 |
| Anika Therapeutics, Inc. | 19.19 |